54 related articles for article (PubMed ID: 646859)
21. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
22. Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.
Bukowski RM; Sharfman W; Murthy S; Rayman P; Tubbs R; Alexander J; Budd GT; Sergi JS; Bauer L; Gibson V
Cancer Res; 1991 Aug; 51(16):4199-205. PubMed ID: 1868441
[TBL] [Abstract][Full Text] [Related]
23. Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding.
Ohnishi K; Bonavida B
J Immunol; 1986 Dec; 137(11):3681-8. PubMed ID: 2946766
[TBL] [Abstract][Full Text] [Related]
24. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
[TBL] [Abstract][Full Text] [Related]
25. Lymphocyte sensitization detected by the macrophage electrophoretic mobility assay in patients with renal cell carcinoma: Theophylline increases the sensitivity of the assay.
Malkovský M; Bubeník J; Malkovská V; Indrová M; Suhajová E; Jakoubková J; Jíra M
Arch Geschwulstforsch; 1981; 51(4):364-70. PubMed ID: 7032451
[TBL] [Abstract][Full Text] [Related]
26. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
Loskog A; Tötterman TH; Böhle A; Brandau S
Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
[TBL] [Abstract][Full Text] [Related]
27. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
28. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
29. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
30. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
31. [Pre-operative irradiation and tumor-specific immune response in hypernephroid renal carcinoma (author's transl)].
Dietz R; Schwarze G; Pappas A
Strahlentherapie; 1979 Jul; 155(7):466-9. PubMed ID: 115119
[TBL] [Abstract][Full Text] [Related]
32. [Tumor-specific immune response of hypernephroid renal carcinoma after in vitro irradiation (author's transl)].
Dietz R; Schwarze G; Pappas A
Strahlentherapie; 1979 Nov; 155(11):754-6. PubMed ID: 516095
[TBL] [Abstract][Full Text] [Related]
33. [Immunochemical study of the alpha-globulins in human kidney tumor tissue].
Pchelkina ZM; Matveev BP; Rykunov EI; Terent'ev AA; Tatarinov IuS
Vopr Med Khim; 1979; 25(4):439-41. PubMed ID: 89757
[TBL] [Abstract][Full Text] [Related]
34. Discussion paper: tumor-directed cellular hypersensitivity detected by leucocyte migration in patients with renal carcinoma.
Kjaer M; Bendixen G
Ann N Y Acad Sci; 1976; 276():260-71. PubMed ID: 1071963
[TBL] [Abstract][Full Text] [Related]
35. Liposome-facilitated enhancement of in vitro immunity to human colon cancer.
Sengupta J; Klesius PH; Tom BH
Immunol Invest; 1985 Feb; 14(1):7-26. PubMed ID: 3997212
[TBL] [Abstract][Full Text] [Related]
36. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
Brower PA; Dekernion JB; Ramming KP
J Urol; 1976 Mar; 115(3):243-5. PubMed ID: 1255883
[TBL] [Abstract][Full Text] [Related]
37. Autologous mixed lymphocyte tumor cell culture in patients with renal cell carcinoma.
Nakano E; Fujioka H; Ishibashi M; Matsuda M; Osafune M; Takaha M; Sonoda T
J Urol; 1984 Feb; 131(2):223-6. PubMed ID: 6230462
[TBL] [Abstract][Full Text] [Related]
38. [Detection of tumorantigens of hypernephroma (author's transl)].
Bichler KH; Kirchner C; Porzsolt F
Urol Int; 1973; 28(3):184-6. PubMed ID: 4753572
[No Abstract] [Full Text] [Related]
39. HLA-antigens and hypernephroma.
Kuntz BM; Schmidt GD; Scholz S; Albert ED
Tissue Antigens; 1978 Nov; 12(5):407-8. PubMed ID: 746536
[No Abstract] [Full Text] [Related]
40. Tumor membrane lymphocyte stimulation assay in patients with renal cell carcinoma.
Hemstreet GP; Dawson JR; Seigler HF
Cancer Res; 1978 May; 38(5):1447-56. PubMed ID: 646859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
